“…HNP-1 attenuates an LPS-induced IL-1β, but not TNF-α, response in human monocytes (Shi et al 2007 ); DEFA1-3 attenuates P. aeruginosa -induced TNF-α, IL-8, IL-6, and IL-1β responses in human monocyte-derived macrophages (Miles et al 2009 ); and HNP-1 and HNP-3 attenuate P. intermedia LPS-induced IL-1β, IL-8, and ICAM-1 responses in THP-1 human monocytes and HGF cells (Lee et al 2010 ). HBD1, HBD2, HBD3, and DEFB104A attenuate P. intermedia LPS-induced IL-1β, IL-8, and ICAM-1 responses in THP-1 human monocytes and HGF cells (Lee et al 2010 ); HBD3 attenuates the IL-6, IL-10, GM-CSF, and TNF-α responses of HagB-induced human myeloid dendritic cells (Pingel et al 2008 ); DEFB114 attenuates an LPS-induced TNF-α response in RAW264.7 murine macrophages (Yu et al 2013 ); and DEFB123 (Motzkus et al 2006 ) and DEFB126 (Liu et al 2013a ) attenuate an LPS-induced IL-6 (e.g., DEFB126) and TNF-α (e.g., DEFB123, DEFB126) response in RAW264.7 murine macrophages. Finally, θ-defensin retrocyclin RTD-1 inhibits a TLR2, 4, and 5 agonist-induced TNF-α, IL-1α, IL-1β, IL-6, IL-8, MCP-1 (CCL2), MIP-1α (CCL3), and MIP-1β (CCL4) responses in human peripheral blood leukocytes (Schaal et al 2012 ).…”